ADHD Therapeutics Market to Surpass USD 23.89 Billion by 2035, Driven by Rising ADHD Prevalence and Expanding Mental Health Awareness – SNS Insider
Growing Adoption of Stimulant and Non-Stimulant Medications, Advancements in Long-Acting Drug Formulations, and Personalized Treatment Approaches Drive Market Expansion. Austin,…